Rev-Eyes en es it fr

Rev-Eyes Brand names, Rev-Eyes Analogs

Rev-Eyes Brand Names Mixture

  • No information avaliable

Rev-Eyes Chemical_Formula


Rev-Eyes RX_link

No information avaliable

Rev-Eyes fda sheet

Rev-Eyes msds (material safety sheet)

Rev-Eyes MSDS

Rev-Eyes Synthesis Reference

No information avaliable

Rev-Eyes Molecular Weight

325.451 g/mol

Rev-Eyes Melting Point

No information avaliable

Rev-Eyes H2O Solubility


Rev-Eyes State


Rev-Eyes LogP

No information avaliable

Rev-Eyes Dosage Forms

Ophthalmic solution (eye drops, 0.5%); Ophthalmic powder for reconstitution (0.5%)

Rev-Eyes Indication

Used in the treatment of iatrogenically induced mydriasis produced by adrenergic (phenylephrine) or parasympatholytic (tropicamide) agents used in certain eye examinations.

Rev-Eyes Pharmacology

Dapiprazole is an alpha-adrenergic blocking agent. It produces miosis by blocking the alpha-adrenergic receptors on the dilator muscle of the iris. Dapiprazole produces no significant action on ciliary muscle contraction and thus, there are no changes in the depth of the anterior chamber of the thickness of the lens. It does not alter the IOP either in normal eyes or in eyes with elevated IOP. The rate of pupillary constriction may be slightly slower in clients with brown irises than in clients with blue or green irises.

Rev-Eyes Absorption

Systemic absorption is negligible.

Rev-Eyes side effects and Toxicity

Oral LD50 is 1189—2100 mg/kg in mice, rats and rabbits.

Rev-Eyes Patient Information

Rev-Eyes Organisms Affected

Humans and other mammals